Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
ESCRS 2023 Recap: Biotech Companies That Stand Out
As OBN, we had the privilege of participating in the ESCRS Congress 2023 held in Vienna, where we witnessed the remarkable efforts of various companies dedicated to enhancing patient outcomes. In this exclusive article, we present a compilation of ten…
What is Penetrating Keratoplasty and How to Perform it
What is Penetrating Keratoplasty? Penetrating Keratoplasty (PKP), also known as a full-thickness corneal transplant, is a significant ophthalmic surgical procedure aimed at restoring visual acuity in patients with corneal diseases. This procedure involves the replacement of the entire corneal tissue…
What Is Corneal Collagen Cross-Linking?
The world of ophthalmology is constantly evolving, with innovative treatments and procedures emerging to address a wide range of eye conditions. One such cutting-edge treatment, corneal collagen cross-linking (CXL), has gained significant attention for its role in managing keratoconus, a…
Geographic Atrophy & Patients With GA
Geographic atrophy (GA), is an advanced form of age-related macular degeneration (AMD), affecting the retina, a part of the eye that sends information to the brain to enable sight. Many people with AMD do not immediately recognise the symptoms, mistaking…
Lotilaner Shows Promise for Treating Demodex Blepharitis
A team of investigators, led by Elizabeth Yeu, MD, from Virginia Eye Consultants in Norfolk, Virginia, reported the safety and efficacy of lotilaner ophthalmic solution, 0.25% (TP-03, Tarsus Pharmaceuticals Inc.), in treating Demodex blepharitis. Demodex mites are the most common…
Irvine-Gass Syndrome: Causes, Symptoms, and Treatment
What Is Irvine–Gass Syndrome? Irvine–Gass Syndrome, also known as cystoid macular edema (CME), is a notable complication that can occur after cataract surgery. It is characterized by the accumulation of fluid in the macula, the central region of the retina…
EyePoint Launches VERONA Trial for EYP-1901 in DME
EyePoint Pharmaceuticals announced the dosing of the first patient in the VERONA clinical trial for their investigational therapy, EYP-1901, for the treatment of Diabetic Macular Edema (DME). EYP-1901, a sustained delivery therapy, incorporates vorolanib, a selective tyrosine kinase inhibitor, formulated…
Roth Spots: Causes, Symptoms and Management
Roth spots are retinal hemorrhages with white or pale centers. They are named after Moritz Roth, who first described them in the late 19th century. In medical terms, Roth spots represent a significant clinical finding as they may indicate an…
What is Hypertensive Retinopathy and How to Manage it
Hypertensive retinopathy is a condition that affects the blood vessels in the eyes and is directly linked to uncontrolled high blood pressure. This condition is a critical example of how hypertension can impact various organs, including the eyes. In this…
Promising Results for First Topical Treatment in DR
Exonate Ltd., a pioneering mRNA therapy company specializing in treatments for diabetic diseases, has announced that its lead ophthalmology asset, EXN407, successfully met prespecified endpoints in a phase Ib/IIa study for diabetic retinopathy and diabetic macular edema. During the trial,…